The Comprehensive Addiction and Recovery Act allows Medicare drug plans to establish pharmacy and prescriber lock-in requirements for subscribers at high risk of abuse or addiction, and the Pharmaceutical Care Management Association is a key player in setting up the programs. The PCMA suggests starting with opioid drugs and says that preferred-network models offer adequate protection.